Class II · Moderate risk Ongoing
Alprazolam C-IV
Reason CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
FDA Drug Recalls
14,450 recalls · Class II, newest first
Class II · Moderate risk Ongoing
Alprazolam C-IV
Reason CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Class II · Moderate risk Terminated
Simvastatin 40 mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Rosuvastatin 40mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Rosuvastatin 10mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Rosuvastatin 5mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Ropinirole 2mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Atorvastatin 20 mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Tadalafil 5 mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Simvastatin 10 mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Rosuvastatin 5mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Ropinirole 0.5 mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Glimepiride 2 mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Doxazosin 2 mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Atorvastatin 10 mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Aripiprazole 5mg tablets
Reason cGMP Deviations
Class II · Moderate risk Terminated
Glimepiride Tablets
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated
Glimepiride Tablets
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated
Glimepiride Tablets
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Ongoing
Aripiprazole Tablets
Reason Out of specification (OOS) for Spectroscopic Identification test by IR.
Class II · Moderate risk Ongoing
Tadalafil Tablets
Reason CGMP Deviations
Class II · Moderate risk Ongoing
Tadalafil Tablets
Reason CGMP Deviations
Class II · Moderate risk Ongoing
Glimepiride Tablets
Reason CGMP Deviations
Class II · Moderate risk Ongoing
Glimepiride Tablets
Reason CGMP Deviations
Class II · Moderate risk Ongoing
Doxazosin Tablets
Reason CGMP Deviations